Navigation Links
Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
Date:10/29/2008

- Study showed no consistent differences in bone mineral density at the lumbar spine and total hip between Advair Diskus 250/50 (fluticasone propionate and salmeterol inhalation powder) and salmeterol

- Study provides support for long term use of Advair(R) in patients with COPD

PHILADELPHIA, Oct. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that data from a three-year study of patients with Chronic Obstructive Pulmonary Disease (COPD) found that the inhaled corticosteroid in Advair Diskus 250/50, fluticasone propionate, did not show an adverse effect on bone mineral density (BMD) measured at the lumbar spine and total hip compared to salmeterol alone. In this study, designed to show equivalent rate of change in BMD for Advair and salmeterol, results for bone mineral density in the lumbar spine did not meet clinical equivalence although the rate of change favored Advair. The data was presented in Philadelphia at CHEST 2008, the annual meeting of the American College of Chest Physicians.

"These data are very encouraging for patients with COPD since most patients with this debilitating disease are at an age where they may also be at risk for bone loss," said Richard ZuWallack, MD of St. Francis Hospital and Medical Center, Hartford CT. "These data inform on the long-term impact of inhaled corticosteroids on bone mineral density."

About the Study

Effects of treatment with Advair Diskus 250/50 or salmeterol 50 mcg on BMD were evaluated in 186 patients (females and males 43 to 87 years of age) with COPD in a 3-year double-blind study. BMD evaluations were conducted at baseline and at 6-month intervals. The study was designed to show equivalence in the rate of change of BMD at the L1-L4 lumbar spine and total hip between Advair and salmeterol (defined as a difference in BMD of +/-1% per year). The difference in the rate of change of BMD for Advair versus salmeterol at the lumbar spine was +0.8% per year
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
2. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
3. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
4. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
5. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
6. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
7. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
8. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
9. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
10. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
11. Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of Centers ... 2015 enrollment data shows that 81 percent of seniors ... and extra discounts at certain pharmacies. The findings were ... pharmacy plans are now the foundation of Medicare Part ...
(Date:1/23/2015)... 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating ... Inc. ("Advaxis" or the "Company") (NASDAQ: ADXS ... duties to shareholders. On January 21, 2015, ... that Advaxis had misrepresented the clinical data for its ...
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... 21, 2007-Novo Nordisk today announced clinical,results from the ... -,the once-daily human GLP-1 analogue. The 26-week study ... in Diabetes) programme,and included 581 patients with type ... widely used oral antidiabetic drugs:,metformin and a sulfonylurea ...
... N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Nymox,Pharmaceutical Corporation ... the Company's recently completed studies of,NX-1207 for ... at,a series of upcoming U.S. urology meetings, ... Urological Association Meeting in,Colorado Springs. These independent ...
Cached Medicine Technology:Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 2Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 3Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 4Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... 26, 2014 It is said that nothing ... Today, UWDress.com, the famous wedding dress supplier, shows its ... site-wide cocktail gown promotion. , UWDress.com’s navy cocktail gowns ... they come in high fashion styles. Simple dresses in bright ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... HealthDay Reporter , TUESDAY, Dec. 7 (HealthDay News) ... more likely to take up smoking than teens whose parents ... research. , In fact, the study authors estimated that ... movies, their risk of starting to smoke could drop two ...
... News) -- Teens who have health problems have fewer friends ... than they actually are, new research shows. U.S. researchers ... a 1994-1996 survey that asked them about their health and ... health as "excellent" or "very good." The rest of the ...
... ER? A group of computer engineers at Vanderbilt ... available to create robot assistants that can perform effectively ... specialists in emergency medicine at Vanderbilt University Medical Center ... groups have formed an interdisciplinary team to explore the ...
... The John Theurer Cancer Center at Hackensack University Medical ... annual meeting of the American Society of Hematology (ASH) ... ASH meeting is the world,s leading scientific gathering of ... the 40 abstracts from the John Theurer Cancer Center ...
... School of Hygiene & Tropical Medicine (LSHTM) has contributed to ... the occurrence of several common cancers. The study is published ... started and carried out by Professor Peter Rothwell in Oxford, ... of aspirin. These have been primarily concerned with reducing heart ...
... A study published in the December issue of The ... tomography/computed tomography (PET/CT) scans as a potentially useful tool ... with radiofrequency ablation (RFA). RFA, which uses localized thermal ... an alternative treatment for patients unable to undergo surgery ...
Cached Medicine News:Health News:Watching R-rated Movies Ups Odds of Teens Smoking 2Health News:Watching R-rated Movies Ups Odds of Teens Smoking 3Health News:Teens' Poor Health Linked to Fewer Friends 2Health News:Developing robots for the hospital emergency room 2Health News:Developing robots for the hospital emergency room 3Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 2Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 3Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 4Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 5Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 6Health News:John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers 7Health News:Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent 2Health News:Fewer guessing games for lung cancer patients 2
All Day Comfort for the Lower Body...
Designed for special procedures, this Wrap-Around apron has .50mm Pb in the front and .25mm Pb in the back. The velcro fasteners are adjustable to provide the most comfortable fit....
Setting a new standard in protective apparel. The unique, patented Cool-Tech™ mesh-back design fits the natural contour of the body while reducing the amount of weight carried on the shoulders ...
Protect your thyroid with a personal Thyroid Shield. While other shields have a rough, abrasive bias binding edging the neck, these have a softer, smoother turned seam that helps protect your neck fr...
Medicine Products: